IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+20.5%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+20.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202551.28%
2024-143.23%
2023-115.08%
2022-24.34%
2021-42.22%
202020.16%
2019-21.57%
2018-152.23%
20170.00%